A recent patient-level meta-analysis yielded similar conclusion that sPD-L1 changes during ICIs treatment did not influence the prognosis of NSCLC patients regardless of sex, age and ICI type (55). The gene discussed is SPDL1; the disease is non-small cell lung carcinoma.